Company Profile
Updated: 26-OCT-09BB Biotech AG
International public company
Vordergasse 3, Schaffhausen, CH-8200, Switzerland
()41 041 724 59 59, 41 041 724 59 58 fax, http://www.bbbiotech.com
Primary SIC: Misc. Business Credit Institutions, Primary NAICS: All Other Non-Depository Credit Intermediation
Description: Finance: Holding company with interests in investments in the biotechnology sector, chiefly in the United States. The company is managed by the Bellevue Asset Management Group in Zug, Switzerland and Bellevue Research Inc., Boston, USA
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/4/2009; 1869 words; ...purchased the assets of Elegene AG, of Munich, Germany, including...Cambridge, Mass., and British Biotech plc, of Oxford, UK, said patient...Phase I study of huN901-DM1/BB-10901, an agent targeted against...increasing doses of huN901-DM1/BB-10901. Evidence of biological...
Germany's Neuer Markt Closing Amid Mounting Losses, Scandals.
BIOWORLD Today; 11/4/2009; 879 words; ...Correspondent MUNICH, Germany - Deutsche Boerse AG, the company that operates Germany's most...companies listed on the Neuer Markt. Larger biotech companies listed on the market, such as BB Biotech AG, of Schaffhausen, Switzerland (market cap...
Pevion Gets $29M For Vaccine Pipeline.
BIOWORLD Today; 11/3/2009; 950 words; ...originally developed at Berna Biotech, to which it now has an...Switzerland-based BZ Bank AG led the funding transaction...other participants included BB Biotech Ventures II LP, which is...Bellevue Asset Management AG, and CC Private Equity...
Molecular Partners Gets $15M For Multiuse DARPin Proteins.
BIOWORLD Today; 11/3/2009; 839 words; ...International Correspondent Molecular Partners AG raised CHF18.5 million (US$15...profitable antibody firm Morphosys AG, of Martinsried, Germany. Molecular...Ventures. The other participants included BB Biotech Ventures, Johnson & Johnson Development...
DNAPrint's $35M Stock Sale Will Finance German Buy-In.
BIOWORLD Today; 11/3/2009; 1071 words; ...based pharmaceutical firm Biofrontera AG. "It's a different approach," said...there aren't many options out there for biotech companies that are in need of cash." The company's stock (OTC BB:DNAP) closed Wednesday at 2 cents...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning